🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 603693102
- Market Cap
- Micro Cap
- IPO
- 10/15/2021 · $12.00/share
Business: MiNK Therapeutics, Inc is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted platform of invariant natural killer T (iNKT) cells.
Company Contact
- CEO
- Jennifer S. Buell
- CFO
- Christine M. Klaskin
- Headquarters
- 149 Fifth Avenue, Suite 500, New York, NY 10010
- Phone
- 212-994-8250
- Investor Relations
- Kimberly Ha, KKH Advisors · 917-291-5744 · kimberly.ha@kkhadvisors.com